Bank of America
ENZN

Bank of America’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Bank of America’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,023
Closed -$1K – 7640
2015
Q3 		$1K Sell
1,023
-1,273
-55% -$1.57K ﹤0.01% 7119
2015
Q2 		$3K Buy
2,296
+2,293
+76,433% +$2.92K ﹤0.01% 7008
2015
Q1 		$0 Hold
3
– – ﹤0.01% 7947
2014
Q4 		$0 Buy
3
+2
+200% +$2 ﹤0.01% 8239
2014
Q3 		$0 Sell
1
-182,724
-100% -$226K ﹤0.01% 8354
2014
Q2 		$190K Buy
182,725
+182,708
+1,074,753% +$174K ﹤0.01% 5610
2014
Q1 		$0 Sell
17
-8,528
-100% -$8.81K ﹤0.01% 8401
2013
Q4 		$10K Sell
8,545
-16,513
-66% -$25.4K ﹤0.01% 7299
2013
Q3 		$42K Sell
25,058
-75,657
-75% -$140K ﹤0.01% 6524
2013
Q2 		$201K Buy
+100,715
New +$295K ﹤0.01% 5616

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.42B AUM 22.12% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of America's ENZN Position: Q4 2015 in Review

Bank of America sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q4 2015, closing a stake of 1,023 shares — an estimated $1K sold.

Bank of America first reported a position in ENZN in Q2 2013 and held it in 10 quarters. The position peaked at $201K in Q2 2013. 49 funds tracked by Wall St. Rank hold ENZN as of Q4 2015.

  • Bank of America reported no remaining ENZON PHARMACEUTICALS INC position as of Q4 2015 after selling out during the quarter.
  • Bank of America sold 1,023 ENZON PHARMACEUTICALS INC shares in Q4 2015, an estimated $1K.
  • Bank of America first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 10 quarters.
  • Bank of America's ENZON PHARMACEUTICALS INC position peaked at $201K in Q2 2013.
  • 49 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q4 2015.

Based on Bank of America's 13F filing for Q4 2015, filed 16 Feb 2016.